EG666747 Inhibitors
Chemical inhibitors of EG666747 can modulate its function through various molecular mechanisms. Trichostatin A, for instance, acts as a histone deacetylase inhibitor, leading to the hyperacetylation of proteins. By doing so, it can prevent the deacetylation of EG666747, resulting in an altered function due to changes in its acetylation state. Similarly, Bortezomib, by inhibiting the proteasome, can lead to the accumulation of ubiquitinated proteins, which may interfere with the cellular environment of EG666747, thereby impacting its activity. Dasatinib, as a tyrosine kinase inhibitor, can inhibit phosphorylation processes that are crucial for the activity of many proteins. If EG666747 requires phosphorylation for its activity, its function will be affected by dasatinib.
In addition to these inhibitors, LY294002 and Wortmannin act as PI3K inhibitors, directly impacting the PI3K/Akt signaling pathway, which is often critical for the regulation of protein function. If EG666747 is regulated via this pathway, its activity can be impeded. PD98059 and U0126 target the MEK enzyme, a key component of the MAPK/ERK pathway, and their inhibitory action could prevent the phosphorylation of proteins, including EG666747, if it is regulated by this pathway. SB203580 and SP600125, which inhibit p38 MAPK and JNK respectively, can also disrupt signaling pathways that may be necessary for the proper function of EG666747. Rapamycin, an mTOR inhibitor, can suppress protein synthesis and cell growth, which can reduce the activity of EG666747 by impacting its synthesis or the synthesis of interacting factors. MG132, another proteasome inhibitor, can cause the accumulation of ubiquitinated proteins, potentially leading to a compromised function of EG666747. Lastly, ZM-447439, an Aurora kinase inhibitor, can prevent the phosphorylation of proteins during mitosis, which may be essential for the mitotic functions of EG666747, resulting in an inhibited activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can enhance the acetylation of proteins, including EG666747. By preventing deacetylation, Trichostatin A may lead to hyperacetylated states that disrupt the normal function of EG666747. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can inhibit the degradation of ubiquitinated proteins. Accumulation of ubiquitinated proteins may disrupt the cellular environment of EG666747, leading to its functional inhibition. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a tyrosine kinase inhibitor that can inhibit the phosphorylation of proteins involved in signal transduction pathways. If EG666747 requires phosphorylation for its activity, dasatinib may inhibit its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can inhibit the PI3K/Akt signaling pathway. If EG666747 is regulated by this pathway, LY294002 could lead to functional inhibition by blocking downstream signaling required for EG666747's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can inhibit the MAPK/ERK pathway. By blocking this pathway, PD98059 could inhibit the phosphorylation of proteins that may be crucial for EG666747's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can inhibit the p38 MAPK signaling pathway. If EG666747's function is contingent on this pathway, SB203580 could inhibit its activity by blocking necessary signaling events. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can inhibit the mTOR signaling pathway. Since mTOR is involved in protein synthesis and cell growth, inhibiting mTOR with rapamycin could reduce the functional activity of EG666747 by suppressing its synthesis or the synthesis of factors it interacts with. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which in turn is part of the MAPK/ERK pathway. By inhibiting MEK, U0126 can disrupt the phosphorylation of proteins, potentially leading to inhibition of EG666747's function if it is regulated by this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, which can block the PI3K/Akt pathway. If EG666747's activity is regulated through this pathway, wortmannin could inhibit its function by preventing activation signals. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK signaling pathways. By inhibiting JNK, SP600125 could prevent the phosphorylation of proteins that are essential for the functional activity of EG666747. | ||||||